There are 2949 resources available
1445P - CS1001, an anti-PD-L1 antibody, combined with standard of care (SOC) chemotherapy for first line (1L) advanced GC/GEJ and ESCC: Preliminary results from 2 phase Ib cohorts of CS1001-101 study
Presenter: Lin Shen
Session: E-Poster Display
Resources:
Abstract
1446P - Initial safety and efficacy findings with bavituximab plus pembrolizumab in patients with advanced gastric or gastroesophageal cancer
Presenter: Ian Chau
Session: E-Poster Display
Resources:
Abstract
1447P - S-1 maintenance therapy in non-Asian patients with advanced, Her-2 negative esophagogastric adenocarcinoma – First results of the international MATEO trial initiated by the AIO
Presenter: Georg Martin Haag
Session: E-Poster Display
Resources:
Abstract
1448P - Paclitaxel and cisplatin combined with anlotinib as first line regimen for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, multicentre open-label phase II clinical trial
Presenter: Jun-Sheng Wang
Session: E-Poster Display
Resources:
Abstract
1449P - Hospital volume and beyond first-line palliative systemic treatment administration in metastatic esophagogastric adenocarcinoma: A population-based study
Presenter: Willemieke Dijksterhuis
Session: E-Poster Display
Resources:
Abstract
1450P - Efficacy and safety analysis of modified biweekly SOX regimen in the first-line treatment of advanced gastric adenocarcinoma or esophagogastric junction adenocarcinoma
Presenter: Shu Zhang
Session: E-Poster Display
Resources:
Abstract
1451P - Comparative response evaluation of cisplatin-capecitabine with cisplatin-5-fluorouracil in advanced gastric carcinoma: A quasi-experimental study
Presenter: Ariful Hoque
Session: E-Poster Display
Resources:
Abstract
1452P - Phase I study of apatinib plus POF (paclitaxel plus FOLFOX) in patients (pts) with treatment-naïve advanced gastric cancer (TNAGC)
Presenter: Rongbo Lin
Session: E-Poster Display
Resources:
Abstract
1453P - Safety and efficacy of vactosertib, a TGF-βR1 kinase inhibitor, in combination with paclitaxel in patients with metastatic gastric adenocarcinoma
Presenter: Minkyu Jung
Session: E-Poster Display
Resources:
Abstract
1454P - PARAFIRIGAST: Paclitaxel/ramucirumab versus FOLFIRI as second line chemotherapy of metastatic gastric cancer: An AGEO multicenter comparative study with a propensity score analysis
Presenter: Julie Wasselin
Session: E-Poster Display
Resources:
Abstract